Steward Partners Investment Advisory, LLC - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 179 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
Steward Partners Investment Advisory, LLC ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$600
-53.8%
1,0000.0%0.00%
Q2 2023$1,300
-26.1%
1,0000.0%0.00%
Q1 2023$1,760
-43.9%
1,0000.0%0.00%
Q4 2022$3,140
-73.8%
1,000
-60.0%
0.00%
Q3 2022$12,000
+20.0%
2,5000.0%0.00%
Q2 2022$10,000
-47.4%
2,500
-22.4%
0.00%
Q1 2022$19,000
-20.8%
3,2220.0%0.00%
Q4 2021$24,000
-25.0%
3,222
-9.5%
0.00%
-100.0%
Q3 2021$32,000
-25.6%
3,5620.0%0.00%0.0%
Q2 2021$43,000
-100.0%
3,562
-50.0%
0.00%0.0%
Q1 2021$89,264,000
+159300.0%
7,124
+100.0%
0.00%0.0%
Q4 2020$56,000
+47.4%
3,562
-12.3%
0.00%0.0%
Q3 2020$38,000
+5.6%
4,0620.0%0.00%0.0%
Q2 2020$36,000
+38.5%
4,062
-2.4%
0.00%0.0%
Q1 2020$26,000
-31.6%
4,162
-8.9%
0.00%0.0%
Q4 2019$38,000
-9.5%
4,571
-2.0%
0.00%0.0%
Q3 2019$42,000
-16.0%
4,6620.0%0.00%
-50.0%
Q2 2019$50,000
-39.0%
4,662
-3.1%
0.00%
-50.0%
Q3 2018$82,000
+41.4%
4,812
+18.5%
0.00%
+33.3%
Q2 2018$58,000
-30.1%
4,062
-7.4%
0.00%
-50.0%
Q1 2018$83,000
+16.9%
4,3870.0%0.01%
+20.0%
Q4 2017$71,000
+9.2%
4,3870.0%0.01%
-28.6%
Q3 2017$65,000
+66.7%
4,387
-1.1%
0.01%
+75.0%
Q2 2017$39,000
+69.6%
4,4380.0%0.00%
+33.3%
Q1 2017$23,000
+76.9%
4,4380.0%0.00%
-50.0%
Q4 2016$13,0004,4380.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Alexandria Capital, LLC 1,003,725$15,663,0001.66%
Golden State Equity Partners 123,817$1,932,0001.33%
Rhenman & Partners Asset Management AB 821,888$12,826,0001.05%
WASATCH ADVISORS LP 10,072,381$157,180,0000.77%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 29,636$462,0000.73%
Ceeto Capital Group, LLC 80,000$1,248,0000.63%
EMC Capital Management 48,992$765,0000.58%
Fort Sheridan Advisors LLC 71,173$1,111,0000.54%
Vanguard Capital Wealth Advisors 34,680$584,0000.54%
Casdin Capital, LLC 1,080,000$16,853,0000.50%
View complete list of SANGAMO THERAPEUTICS INC shareholders